The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesothelioma

Cancer Biology and Therapy

Volumn 1, Issue 4, 2002, Pages 347-352

  Powers, Amy ^a   Carbone, Michele ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Asbestos; Genetics; Large T antigen; Simian virus 40

Indexed keywords

ASBESTOS;

ANIMAL; BIOLOGICAL MODEL; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUNG TUMOR; MESOTHELIOMA; PATHOGENICITY; REVIEW; SIMIAN VIRUS 40; VIROLOGY;

ANIMALS; ASBESTOS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; MODELS, BIOLOGICAL; SIMIAN VIRUS 40;

EID: 1842832317     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.4.4     Document Type: Review

References (36)

1. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997; 145:211-18.
2. Roggli VL, Sanfilippo F, Shelburne JD. Mesothelioma. In: Roggli VL, Greenberg SD, Pratt PC, ed. Pathology of asbestos associated diseases. Boston: Little Brown and Co, 1992:109-64.
3. Carbone M, Kratzke PA, Testa JR. The Pathogenesis of Mesothelioma. Seminars in Oncology 2002;29:2-17. (Pubitemid 34163530)
4. Walker AM, Loughlin JE, Friedlander ER, Rothman KJ, Dreyer NA. Projection of asbestos related disease. J Occ Med 1983; 34:718-21.
5. Sluis-Kremer GK. Asbestos disease at low exposures after long residence times. In: Landrigan PJ, Kazemi H, eds. The third wave of asbestos disease: exposure to asbestos in place. New York: Annals New York Aca Science, 1991:74-84.
6. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157:1666-80.
7. Smith AH, Wright CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Industrial Med 1996; 30:252-66. (Pubitemid 26299959)
8. Bignon J, Sebastien P, Gaudichet A, Jaurand MC. Measurement of asbestos retention in the human respiratory system related to human effects. In: NBS Special Publication. Workshop on Asbestos: Definition and measurement methods. 1978: 95-119.
9. Smith WE, Hubert DD. The intrapleural route as a means for estimating carcinogenicity. In: Karbe E, Parke JF, eds. Experimental Lung Cancer, Carcinogenesis and Bioassays. New York, 1974: 92-101.
10. Wagner JC, Berry G, Timbrell V. Mesotheliomata in rats after innoculation with asbestos and other materials. Br J Cancer 1973; 28:173-187.
11. Smith WE. Asbestos, talc, and nitrites in relation to gastric cancer. Amer Ind Hyg Ass J 1973; 34:227-228.
12. Stanton MF, Wretch C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Nat Cancer Inst 1972; 48:797-821.
13. Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br. J Cancer 1974; 29:252-69.
14. Mossman BT, Bignon J, Corn M, Seaton A, Gee JB. Asbestos: scientific developments and implication for public policy. Science 1990; 247:294-301. (Pubitemid 20046453)
15. Mossman BT, Kamp D, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996; 14:464-78.
16. Hughes JM, Weill H. Asbestos exposure -quantitative assessment of risk. Am Rev Respir Dis 1986; 133:5-13. (Pubitemid 16189088)
17. Vanna NJ, Polan AK. Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet 1978; 1:1061-3. (Pubitemid 8356365)
18. Li FP, Jacob L, lapey J. Familial mesothelioma after intense asbestos exposure at home. JAMA 1978; 240:467.
19. Yates DH, Corrin B, Stidolph PN, Browne K. Malignant mesothelioma in southeast England: clinicopathological experience of 272 cases. Thorax 1997; 52:507-12. (Pubitemid 27298500)
20. Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, et al. Human mesothelial cells are unusually susceptible to SV40 mediated transformation and asbestos co-carcinogenicity. Proc Natl Aca Sci 2000; 97:10214-9.
21. Lamphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occupational Medicine 1992; 34:718-21.
22. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999; 91:119-33.
23. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines, and human tumors: a review of recent developments. Oncogene 1997; 15:1877-8
24. Carbone M, Pompetti F, Cicala C, et al. The role of small t antigen in SV40 oncogenesis. In: C Nicolini ed. Molecular basis of human cancer. New York: Plenum Publishing Co, 1991:191-206.
25. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993; 142:1524-33. (Pubitemid 24058139)
26. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, et al. Simian virus 40 like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9:1781-90. (Pubitemid 24163409)
27. Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesothelioma. Cancer Res 1998; 58:4505-9. (Pubitemid 28480603)
28. Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, et al. SV40-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40 contaminated poliovaccines. Mol Carc 1999; 26:93-9. (Pubitemid 29480439)
29. Klein G, Powers A, Croce C. Meeting review: Malignant mesothelioma. Therapeutic options and the role of SV40. Oncogene 2002; 21:1141-9.
30. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, et al. Simian virus 40 large T antigen binds p53 in human mesotheliomas. Nature Med 1997; 8:908-12. (Pubitemid 27353453)
31. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130, and simian virus 40 large T antigen in human mesotheliomas. Nature Med 1997; 3:913-6.
32. Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21:1434-42. (Pubitemid 34214508)
33. Sanders C, Jackson TA. Induction of mesotheliomas and sarcomas from hot spots of 239PuO2 activity. Health Phys 1972; 22:755-9.
34. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001; 357:444-5. (Pubitemid 32156148)
35. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Cancer Biology 2001;11:31-8. (Pubitemid 32222749)
36. Robledo R, Mossman B. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cellular Physio 1999;180:158-66. (Pubitemid 29297192)